SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It operates through the Drug Development and Online Sales segments. The Drug Development segment focuses on cannabinoid molecules to be approved by an official regulatory authority. The Online Sales segment consists of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. SciSparc Ltd market cap is $402,284.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. SciSparc Ltd 52 week high is $29.88 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. SciSparc Ltd 52 week low is $0.1668 as of November 22, 2026.
SciSparc Ltd stock price today is $0.1955.
SciSparc Ltd stock price yesterday was $0.30.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. SciSparc Ltd P/B ratio is 0.0288.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. SciSparc Ltd 50-day moving average is $2.52.